Clinical Trial Update: A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of intravitreal Zimura (avacincaptad pegol) for geographic atrophy and age-related macular degeneration has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Zimura (ARC1905)

Snippet

Sponsor: IVERIC bio, Inc. | Conditions: Geographic Atrophy, Macular Degeneration | Phase 3 | Status: COMPLETED | Results posted: 2023-12-28